SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis.
Rushikesh DeshpandeWangyang LiTiao LiKristen V FanningZachary ClemensToru NyunoyaLianghui ZhangBerthony DeslouchesAaron BarchowskySally WenzelJohn F McDyerChunbin ZouPublished in: International journal of molecular sciences (2024)
The pandemic of coronavirus disease 2019 (COVID-19) has been the foremost modern global public health challenge. The airway is the primary target in severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection, with substantial cell death and lung injury being signature hallmarks of exposure. The viral factors that contribute to cell death and lung injury remain incompletely understood. Thus, this study investigated the role of open reading frame 7b (Orf7b), an accessory protein of the virus, in causing lung injury. In screening viral proteins, we identified Orf7b as one of the major viral factors that mediates lung epithelial cell death. Overexpression of Orf7b leads to apoptosis and ferroptosis in lung epithelial cells, and inhibitors of apoptosis and ferroptosis ablate Orf7b-induced cell death. Orf7b upregulates the transcription regulator, c-Myc, which is integral in the activation of lung cell death pathways. Depletion of c-Myc alleviates both apoptotic and ferroptotic cell deaths and lung injury in mouse models. Our study suggests a major role of Orf7b in the cell death and lung injury attributable to COVID-19 exposure, supporting it as a potential therapeutic target.
Keyphrases
- cell death
- sars cov
- cell cycle arrest
- coronavirus disease
- respiratory syndrome coronavirus
- acute respiratory distress syndrome
- public health
- mouse model
- transcription factor
- oxidative stress
- stem cells
- mesenchymal stem cells
- protein protein
- working memory
- endothelial cells
- drug induced
- intensive care unit
- small molecule
- single cell
- early onset
- cell therapy
- high glucose
- amino acid
- anti inflammatory